Zobrazeno 1 - 10
of 965
pro vyhledávání: '"John A. Vaughn"'
Autor:
Hall, J. Hewitt
Publikováno v:
On Point, 2011 Jan 01. 16(3), 55-55.
Externí odkaz:
https://www.jstor.org/stable/26361273
Autor:
John L. Vaughn, Narendranath Epperla
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-4 (2023)
Abstract Population-based data comparing the outcomes of patients with transformed follicular lymphoma (t-FL) and de novo diffuse large B-cell lymphoma (DLBCL) are lacking. The objective of this study was to compare the survival of patients with t-FL
Externí odkaz:
https://doaj.org/article/5efcada7410b4bcc8841ff0ecf64f5d7
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7330-7338 (2021)
Abstract Background Racial/ethnic disparities in the utilization of hematopoietic cell transplantation (HCT) have been reported for patients with hematologic malignancies, but population‐based data are lacking for lymphoma patients. The objective o
Externí odkaz:
https://doaj.org/article/5c814f23be2442ddb8e215f0096f3856
Autor:
Lasserre, F.
Publikováno v:
Museum Helveticum, 1979 Jan 01. 36(4), 252-252.
Externí odkaz:
https://www.jstor.org/stable/24815559
Autor:
Bannert, Herbert
Publikováno v:
Wiener Studien, 1979 Jan 01. 92, 232-232.
Externí odkaz:
https://www.jstor.org/stable/24746978
Autor:
Bühler, Winfried
Publikováno v:
Gnomon, 1979 Apr 01. 51(2), 178-180.
Externí odkaz:
https://www.jstor.org/stable/27687168
Autor:
Meillier, Claude
Publikováno v:
Revue des Études Grecques, 1984 Jan 01. 97(460/461), 336-336.
Externí odkaz:
https://www.jstor.org/stable/44263903
Recent survival trends in diffuse large B‐cell lymphoma––Have we made any progress beyond rituximab?
Publikováno v:
Cancer Medicine, Vol 9, Iss 15, Pp 5519-5525 (2020)
Abstract Background Population‐based studies previously showed an improvement in overall survival (OS) for patients with diffuse large B‐cell lymphoma (DLBCL) who received chemoimmunotherapy with rituximab. However, there is limited data (especia
Externí odkaz:
https://doaj.org/article/9e8aa261cba64c89b4dc615255f8644b
Publikováno v:
Journal of Medical Case Reports, Vol 11, Iss 1, Pp 1-4 (2017)
Abstract Background Histiocytic sarcoma is a rare histiocytic neoplasm of unknown etiology that constitutes less than 1% of hematologic malignancies. A few cases of histiocytic sarcoma harboring the BRAF V600E mutation have been reported, but this fi
Externí odkaz:
https://doaj.org/article/94125d7e16924c7bac32a1daeaa814eb
Autor:
Campbell, David A.
Publikováno v:
Phoenix, 1979 Dec 01. 33(4), 376-376.
Externí odkaz:
https://www.jstor.org/stable/1087199